Analyst Ratings For NASDAQ:BDSI – BioDelivery Sciences International (NASDAQ:BDSI)
Today, HC Wainwright lowered its price target on NASDAQ:BDSI – BioDelivery Sciences International (NASDAQ:BDSI) to per share.
Some recent analyst ratings include
- 1/26/2018-Seaport Global Securities initiated coverage with a Buy ➝ Buy rating.
Recent Insider Trading Activity For NASDAQ:BDSI – BioDelivery Sciences International (NASDAQ:BDSI)
NASDAQ:BDSI – BioDelivery Sciences International (NASDAQ:BDSI) has insider ownership of 7.73% and institutional ownership of 46.14%.
- On 4/10/2018 Mark A Sirgo, Director, sold 100,000 with an average share price of $2.06 per share and the total transaction amounting to $206,000.00.
- On 4/6/2018 Paolantonio Ernest Robert De, CFO, sold 64,155 with an average share price of $2.09 per share and the total transaction amounting to $134,083.95.
- On 3/8/2018 Francis E Odonnell Jr, Director, sold 113,876 with an average share price of $2.14 per share and the total transaction amounting to $243,694.64.
- On 1/19/2018 Mark A Sirgo, Director, sold 709,502 with an average share price of $2.73 per share and the total transaction amounting to $1,936,940.46.
- On 1/17/2018 Mark A Sirgo, Director, sold 108,000 with an average share price of $2.57 per share and the total transaction amounting to $277,560.00.
- On 1/3/2018 Mark A Sirgo, Director, sold 162,509 with an average share price of $2.78 per share and the total transaction amounting to $451,775.02.
- On 9/21/2017 Mark A Sirgo, Insider, sold 201,373 with an average share price of $2.84 per share and the total transaction amounting to $571,899.32.
Recent Trading Activity for NASDAQ:BDSI – BioDelivery Sciences International (NASDAQ:BDSI)
Shares of NASDAQ:BDSI – BioDelivery Sciences International closed the previous trading session at 2.32 up +0.03 1.09% with 2.3499999046325684 shares trading hands.